People with a specific type of gene that researchers have referred to as the "sweet tooth gene" are more likely to successfully fight obesity using weight loss drugs, the Cleveland Clinic concluded in a study published in early September .

The study found that individuals with certain variations of Neurobeachin, called the the "sweet tooth gene" by researchers because it's associated with a preference to eat more sweets, are more likely to have success losing weight when using GLP-1 agonist medications, including Ozempic and Trulicity. These are a class of medications that mainly help manage blood sugar levels for people with Type 2 diabetes, but some have also been shown to treat obesity.

This research could change the way obesity is treated, Daniel Rotroff, one of the authors and cha

See Full Page